| LARIMAR THERAP.I. DL-,001 |
| USA |
| Gesundheit |
| US5171251003 / A2P5PP |
| ZA71 (Frankfurt) |
| FRA:ZA71, ETR:ZA71, ZA71:GR |
| - |
| https://larimartx.com/ |
|
Larimar Therapeutics Inc. is a biotechnology company dedicated to developing treatments for complex rare diseases. The company's primary focus is on addressing unmet medical needs, particularly in the..
>Volltext.. |
| 204.28 Mio. EUR |
| 58.34 Mio. EUR |
| - |
| -118.43 Mio. EUR |
| -112.11 Mio. EUR |
| -1.64 EUR |
| 3.69 Mio. EUR |
| 76.56 Mio. EUR |
| -81.95 Mio. EUR |
| 3.89 |
| - |
| -93.36% |
| - |
| - |
| - |
| - |
| LARIMAR |
| 25.02.26 |
|